BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2004
View Archived Issues
First report of selective epsilon opioid receptor agonist
Read More
Role of oleamide and anandamide in food intake and sexual behavior in rats
Read More
Cephalon completes acquisition of CIMA Labs
Read More
Novel parenteral carbapenem against multidrug-resistant bacteria
Read More
Endo closes agreement to market Frova in North America
Read More
Macugen NDA accepted for review
Read More
Karo Bio continues progress across several research areas
Read More
Bivalent ligand selectively targets spinal cord delta-kappa heterodimers
Read More
Multichannel blocker attenuates arrhythmia and cardiac failure
Read More
Eisai presents novel SERM derivatives
Read More
Selective prostaglandin D2 receptor antagonist for the treatment of allergic rhinitis
Read More
Arena claims new 5-HT2A receptor modulators and their therapeutic use
Read More
New HGF modulators prepared and tested at Angion Biomedica
Read More
Novel PDE4 inhibitors in early development at Almirall Prodesfarma
Read More
Artesian researchers claim dual beta-AR/PDE3 inhibitors
Read More
New EGFR inhibitors identified by Ariad scientists
Read More
Two series of histamine H3 antagonists/inverse agonists designed at GSK
Read More
Dual NK1 antagonists/5-HT reuptake inhibitors presented by AstraZeneca
Read More
New phase I/II study of CG-7870 plus Taxotere for prostate cancer
Read More
Antigen Express and Massachusetts General Hospital collaborate in HIV
Read More
MedImmune advances IL-9 monoclonal antibody into new phase I study
Read More
SBIR grant supports development of improved interferon beta analogues
Read More
BioPort IND accepted for anthrax immunity stimulating molecule
Read More
Taxotere approved for early-stage breast cancer
Read More
Viventia Biotech and Acceptys enter option agreement for anticancer antibodies
Read More
Protox Therapeutics retains CTBR for preclinical testing of PSA-PA1
Read More
Abbott presents results of a neuronal nicotinic receptor agonist with analgesic activity
Read More